Inhibition by catecholamines of cholinergic neurotransmission in canine bronchi in vitro.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001980:Bronchi / Q000187:drug effects / Q000294:innervation*; D002395:Catecholamines / Q000494:pharmacology*; D003864:Depression, Chemical; D004285:Dogs; D006584:Hexamethonium Compounds / Q000494:pharmacology; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010275:Parasympathetic Nervous System / Q000187:drug effects*; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects*; D013726:Terbutaline / Q000494:pharmacology; D013779:Tetrodotoxin / Q000494:pharmacology; D014700:Verapamil / Q000494:pharmacology
D002395:Catecholamines; D006584:Hexamethonium Compounds; D013779:Tetrodotoxin; D001285:Atropine; D011433:Propranolol; D014700:Verapamil; D007545:Isoproterenol; D013726:Terbutaline; D009638:Norepinephrine; D010646:Phentolamine